MEDIX vs. DBLEX
Compare and contrast key facts about MFS Emerging Markets Debt Fund (MEDIX) and DoubleLine Emerging Markets Fixed Income Fund (DBLEX).
MEDIX is managed by MFS. It was launched on Mar 17, 1998. DBLEX is managed by DoubleLine. It was launched on Apr 5, 2010.
Performance
MEDIX vs. DBLEX - Performance Comparison
Loading graphics...
MEDIX vs. DBLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MEDIX MFS Emerging Markets Debt Fund | -2.03% | 12.48% | 5.92% | 9.42% | -15.97% | -2.40% | 8.01% | 14.12% | -4.99% | 9.64% |
DBLEX DoubleLine Emerging Markets Fixed Income Fund | -0.99% | 8.39% | 8.20% | 9.64% | -15.30% | 1.97% | 4.85% | 11.80% | -3.20% | 8.48% |
Returns By Period
In the year-to-date period, MEDIX achieves a -2.03% return, which is significantly lower than DBLEX's -0.99% return. Over the past 10 years, MEDIX has underperformed DBLEX with an annualized return of 3.49%, while DBLEX has yielded a comparatively higher 4.02% annualized return.
MEDIX
- 1D
- -0.16%
- 1M
- -4.12%
- YTD
- -2.03%
- 6M
- 1.30%
- 1Y
- 8.04%
- 3Y*
- 7.84%
- 5Y*
- 1.78%
- 10Y*
- 3.49%
DBLEX
- 1D
- 0.00%
- 1M
- -1.75%
- YTD
- -0.99%
- 6M
- -0.82%
- 1Y
- 4.59%
- 3Y*
- 7.81%
- 5Y*
- 1.88%
- 10Y*
- 4.02%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
MEDIX vs. DBLEX - Expense Ratio Comparison
MEDIX has a 0.81% expense ratio, which is lower than DBLEX's 0.90% expense ratio.
Return for Risk
MEDIX vs. DBLEX — Risk / Return Rank
MEDIX
DBLEX
MEDIX vs. DBLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MFS Emerging Markets Debt Fund (MEDIX) and DoubleLine Emerging Markets Fixed Income Fund (DBLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MEDIX | DBLEX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.92 | 1.73 | +0.19 |
Sortino ratioReturn per unit of downside risk | 2.64 | 2.23 | +0.41 |
Omega ratioGain probability vs. loss probability | 1.40 | 1.40 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 2.09 | 1.62 | +0.47 |
Martin ratioReturn relative to average drawdown | 8.43 | 7.17 | +1.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MEDIX | DBLEX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.92 | 1.73 | +0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.42 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.60 | 0.87 | -0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.96 | 0.98 | -0.02 |
Correlation
The correlation between MEDIX and DBLEX is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
MEDIX vs. DBLEX - Dividend Comparison
MEDIX's dividend yield for the trailing twelve months is around 4.80%, less than DBLEX's 5.12% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MEDIX MFS Emerging Markets Debt Fund | 4.80% | 5.22% | 5.68% | 4.90% | 5.51% | 4.33% | 4.07% | 4.59% | 4.87% | 4.46% | 4.86% | 5.25% |
DBLEX DoubleLine Emerging Markets Fixed Income Fund | 5.12% | 5.59% | 5.97% | 5.54% | 4.77% | 4.00% | 4.37% | 4.57% | 3.83% | 4.33% | 4.54% | 5.21% |
Drawdowns
MEDIX vs. DBLEX - Drawdown Comparison
The maximum MEDIX drawdown since its inception was -35.31%, which is greater than DBLEX's maximum drawdown of -25.43%. Use the drawdown chart below to compare losses from any high point for MEDIX and DBLEX.
Loading graphics...
Drawdown Indicators
| MEDIX | DBLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.31% | -25.43% | -9.88% |
Max Drawdown (1Y)Largest decline over 1 year | -4.12% | -2.77% | -1.35% |
Max Drawdown (5Y)Largest decline over 5 years | -27.40% | -25.43% | -1.97% |
Max Drawdown (10Y)Largest decline over 10 years | -27.40% | -25.43% | -1.97% |
Current DrawdownCurrent decline from peak | -4.12% | -1.81% | -2.31% |
Average DrawdownAverage peak-to-trough decline | -4.46% | -3.52% | -0.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.02% | 0.63% | +0.39% |
Volatility
MEDIX vs. DBLEX - Volatility Comparison
MFS Emerging Markets Debt Fund (MEDIX) has a higher volatility of 1.49% compared to DoubleLine Emerging Markets Fixed Income Fund (DBLEX) at 0.66%. This indicates that MEDIX's price experiences larger fluctuations and is considered to be riskier than DBLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MEDIX | DBLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.49% | 0.66% | +0.83% |
Volatility (6M)Calculated over the trailing 6-month period | 2.60% | 1.42% | +1.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 4.47% | 2.61% | +1.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 5.83% | 4.52% | +1.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5.84% | 4.65% | +1.19% |